Early bird registration is open and closes May 2025. Register now
Abstracts deadline Friday 24 April 2026! Submit now
Improving the quality of our lives through state-of-the-art R&D capabilities.
Life science, with outstanding R&D competence and new drugs that have been approved by USFDA for the first time in Korea, is LG Chem’s new growth engine in the mid to long term. We are aggressively making inroads in overseas markets and expanding pipelines for new drugs through constant investment and reinforcing R&D, with aspirations to become one of the top global pharmaceutical companies.
Have you submitted your abstract yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.
Have you registered yet? Don't miss your chance on attending live sessions featuring the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.
